Antiviral therapy during compensated cirrhosis most cost-effective approach
Friday, May 28, 2010 - 08:10
in Health & Medicine
Researchers at the UCLA Medical Centre found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due to hepatitis C (HCV) infection. Full details appear in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD)...